Media Centre
News

Herzog Fox & Neeman Represents Entera Bio in $270m Amgen Licensing Deal

Dan Sharot Ofer Granot Yair Geva Tomer Farkash

11 December 2018

Herzog Fox & Neeman Partners Yair Geva, Tomer Farkash, Dan Sharot, and Ofer Granot, together with Associate Michal Shirin,  represented Israeli biopharmaceutical company Entera Bio in a $270 million research collaboration and licensing agreement deal with California-based, biopharmaceutical company Amgen Inc.

Entera will use its proprietary drug delivery platform to develop oral formulations for one preclinical large molecule program that  Amgen  has selected.  Amgen also has an option to select up to two additional programs to include in the collaboration.

Click here for further reading.

Have a question on this topic? We are here to help

Every case is unique. Let's talk about yours.

Contact Us Now

More News, Insights & Events

Cybersecurity and AI Convergence: Legal, Transactional, and Valuation Implications for 2026 Meet our new Partners – 2026 Herzog Expands Legal Tech Capabilities with Harvey AI
JOIN OUR
Newsletter

    © 2020, All rights reserved, Herzog Law
    Site by Gootte

    The information contained in this web site is provided for informational purposes only and should not be construed as legal advice on any subject matter and should not be relied upon as such. Herzog accepts no responsibility for any consequences whatsoever arising from use of the information contained in this web site. The accessing of information contained in this web site shall under no circumstances be considered as creating an attorney-client relationship between Herzog and any party accessing this web site. Contacting through email any lawyer named in this web site or sending information without prior agreement of Herzog shall not be construed as automatically creating an attorney-client relationship between Herzog and the party sending an email or information. The material contained in this web site has been created by and remains the property of Herzog. No reproduction, transmission, publication or any other form of dissemination shall be permitted unless the prior written consent of Herzog has been obtained. This web site may contain links to other web sites operated by third parties. Herzog does not sponsor, approve or endorse the content of any such web site and is not responsible for the materials appearing in such sites.